Skip to main content
OpenTrials
Completed

NCT Number: NCT06312163

Validation of Innovative Scheimpflug Topography Derived RGP Contact Lens Designs In Optometry Network

The goal of this Prospective, single-site, cohort study is to validate rigid gas permeable corneal contact lens (RGP) designs for keratoconus derived from combining the data from corneal topography scans and contact lenses ordered in patients with keratoconus (KC) attending a UK tertiary NHS Hospital contact lens clinic. The main questions it aims to answer are:

* Does a Scheimpflug topography derived RGP contact lens design for keratoconus have the equivalent overall contact lens fit as the patients' own lens? * Is the number of trial lenses required to fit a patient is reduced compared to standard practice? * Is the time taken to fit a contact lens is reduced compared to standard practice? * Is there user acceptance of the new lens? * Are the Axial ege lift (AEL) changes clinically significant?

There will be 3 work packages

WP1: For each participant data collection will take place over two visits.

• Visit 1: Pentacam topography scans and optimal 'virtual' lens selection will take place. • • Visit 2: Participants are fitted with 4 contact lenses (i) the optimal lens design as specified by the virtual fitting module, (ii) a contact lens with a clinically significant step flatter AEL (iii) a contact lens steeper in axial edge lift (AEL) (iv) the participant's own contact lens.

Each CL fit will be assessed with slit lamp photography according to the standardised method proposed by Wolffsohn et al. (2013), Anterior segment OCT MS39) (CSO Hansom Instruments, UK) and best-corrected visual acuity with each lens design using high-contrast logMAR .

WP2. Participants will attend one appointment where a traditional lens fit, and a lens fitted using the topography guided 'virtual' module will be undertaken (with the fitting method selected for each eye randomised). For each fitting method the total fitting time will be measured and the total number of trial contact lenses used. Patients will be invited to complete a questionnaire that probes their satisfaction of this process.

WP3. Clinicians not involved in the study will be invited to examine a demo version of the virtual fitting module and complete the validated system usability scale tool.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Keratoconus Corneal Diseases Eye Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Moorfields Eye Hospital NHS Foundation Trust

London, EC1V 2PD, United Kingdom

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • - WP1:
  • (a) Presence of keratoconus in either eye
  • (b) Currently using a rigid gas permeable contact lens correction
  • (c) Male or female, aged 18 years or older
  • (d) The absence of significant media opacities
  • (e) No ocular pathology other than keratoconus
  • (f) Ability to understand nature/purpose of the study and to provide informed consent
  • (g) Ability to follow instructions and complete the study
  • (h) Ability to speak English
  • WP2:
  • (a) Presence of keratoconus in both eyes
  • (b) Male or female, aged 18 years or older
  • (c) The absence of significant media opacities
  • (d) No ocular pathology other than keratoconus
  • (e) Ability to understand nature/purpose of the study and to provide informed consent
  • (f) Ability to follow instructions and complete the study
  • (g) Ability to speak English
  • WP3:
  • (a) Optometrist, dispensing optician or ophthalmologist registered with the General Optical Council
  • (b) Works within contact lens service at Moorfields Eye Hospital
  • (c) Ability to understand nature/purpose of the study and to provide informed consent
  • (d) Ability to follow instructions and complete the study
  • (e) Ability to speak English .

Exclusion criteria

  • - WP1:
  • (a) Any systemic disease likely to affect visual performance
  • (b) Any ocular disease that may affect visual performance, other than keratoconus
  • (c) Hearing impairment sufficient to interfere with hearing instructions
  • (d) Poor understanding of English language and/or alphabet
  • (e) Any condition which, in the investigator's opinion, would conflict or otherwise prevent the participant from
  • complying with the required procedures, schedule, or other study conduct.
  • (f) Not currently using a rigid gas permeable contact lens or a contraindication to this
  • (g) A history of corneal graft surgery (keratoplasty) in the eye under investigation.
  • (h) A recent history (in preceding 12 months) of corneal abrasions in the designated study eye
  • (i) A recent history (in preceding 1 month) of corneal cross linking for keratoconus
  • WP2:
  • (a) Any systemic disease likely to affect visual performance
  • (b) Any ocular disease that may affect visual performance, other than keratoconus
  • (c) Hearing impairment sufficient to interfere with hearing instructions
  • (d) Poor understanding of English language and/or alphabet
  • (e) Any condition which, in the investigator's opinion, would conflict or otherwise prevent the participant from
  • complying with the required procedures, schedule, or other study conduct.
  • (f) A contraindication to rigid gas permeable contact lens wear
  • (g) A history of corneal graft surgery (keratoplasty) in the eye under investigation.
  • (h) A recent history (in preceding 12 months) of corneal abrasions in the either eye
  • (i) A recent history (in preceding 1 month) of corneal cross linking for keratoconus
  • WP3:
  • (a) An optometrist dispensing optician or ophthalmologist not fully registered with the General Optical Council (e.g., a pre-registration optometrist)
  • (b) Hearing impairment sufficient to interfere with hearing instructions
  • (c) Poor understanding of English language and/or alphabet
  • (d) Any condition which, in the investigator's opinion, would conflict or otherwise prevent the participant from complying with the required procedures, schedule, or other study conduct.

Treatment and study plan

The contact lens to be investigated in this study (Scheimpflug topography derived corneal RGP contact lens design). A CE (UKCA) marked class 2 medical devices.

Device

The participants will be fitted with (i) the optimal lens design as specified by the virtual fitting module, in addition to (ii) lenses that are one clinically significant step (0.12 mm) flatter and (iii) steeper in axial edge lift (AEL).

Primary outcomes

  1. Rigid gas permeable contact lens fit

    Time frame: 18 months

    The CL fit will be assessed through (i) slit lamp photography according to the standardised method proposed by Wolffsohn et al. (2013), (ii) slit lamp video of lens movement following blink in the primary position and horizontal version movements, and (iii) Anterior segment OCT MS39) (CSO Hansom Instruments, UK).

Secondary outcomes

  1. The changes in contact lens fit from increased and decreased Axial Edge lift

    Time frame: 18 months

    Fluorescein intensity measures Wolffsohn et al. (2013) will be used to examine the predicted vs. observed alterations in contact lens fit when AEL is varied

  2. Best corrected Visual Acuity

    Time frame: 18 months

    Best-corrected visual acuity with each lens design (incorporating an over-refraction where needed) will be measured using high-contrast logMAR in a forced-choice manner.

  3. Clinician Usability Assessment

    Time frame: 18 Months

    Clinician Usability Assessment of topography guided virtual contact lens selection module

Sponsors and collaborators

Lead sponsor

Moorfields Eye Hospital NHS Foundation Trust

Other

Registry information

Acronym: VISION

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Mar 15, 2024
Registry last updated
Mar 15, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.